Immix Biopharma, Inc. IMMX Proceeds From Stock Warrants Exercised
Proceeds From Stock Warrants Exercised at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept IMMX:ProceedsFromStockWarrantsExercised.
The official record: Immix Biopharma, Inc.’s 10-K/A, filed March 27, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s proceeds from stock warrants exercised.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s proceeds from stock warrants exercised?
- Immix Biopharma, Inc. (IMMX) reported proceeds from stock warrants exercised of $31.2K in Q4 2025.
- What does proceeds from stock warrants exercised mean?
- This represents the cash inflows received by the company when holders of stock warrants exercise their right to purchase common shares at a predetermined price. It serves as a source of non-dilutive or secondary capital that strengthens the balance sheet without requiring traditional debt or equity offerings. Tracking this provides insight into potential future dilution and the company's ability to generate liquidity from existing derivative instruments.